Dendritic Cells (DCs) represent the most efficient professional antigen-presenting cells (APC) and, in a tumoral contest, they recognize, process, and present tumor-associated antigens (TAA) complexed to major histocompatibility complex (MHC) molecules. Here, HLA-C is linked to neoplasm.